Suramin inhibits growth and transforming growth factor-β1 (TGF-β1) binding in osteosarcoma cell lines
- 1 January 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (5) , 678-682
- https://doi.org/10.1016/0959-8049(94)90544-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Transforming growth factor-beta: recent progress and new challenges.The Journal of cell biology, 1992
- Receptors for the TGF-β familyCell, 1992
- Growth factors in development, transformation, and tumorigenesisCell, 1991
- Suramin, a novel antitumor compoundThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loopCell, 1990
- Transforming growth factor-β: possible roles in carcinogenesisBritish Journal of Cancer, 1988
- Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cellsJournal of Cellular Physiology, 1987
- Autocrine growth factors and cancerNature, 1985
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980
- Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor virusesCancer Letters, 1979